News and Events
2021
- Stay posted for exciting new updates, coming soon!
2020
- RNA sequencing fails to detect many genetic variants in thyroid tumor, tissue samples
- Study Validates Cytology Smears as an Alternative Sample Type for ThyroSeq Testing
2019
- Data Presented at the 2019 American Association of Clinical Endocrinologists Annual Meeting Demonstrate Performance of ThyroSeq Test in Cytology Smears
- Added Convenience of Classifying Nodules With ThyroSeq Test?
- Molecular Test Promising for Mutations in Thyroid Nodules
- New Data on Diagnostic and Therapeutic Applications of ThyroSeq® Genomic Classifier Presented at the 2019 American Association of Clinical Endocrinologists Annual Meeting
- Validating a Molecular Thyroid Test for Avoiding Diagnostic Surgery
2018
- UPMC’s Pioneering Thyroid Cancer Test Is Now Covered by Medicare
- Genomic Test Helps Identify Thyroid Nodules That Don’t Require Surgery
- Multigene Classifier Test for Thyroid Nodules With Indeterminate Cytology
- Genetic Test Helps ID Benign Versus Malignant Thyroid Nodules
- ThyroSeq® Genetic Test Can Help Most Patients Avoid Unnecessary Diagnostic Thyroid Surgeries, JAMA Oncology Study Shows
- ThyroSeq® Approved for Medicare Coverage to Improve Thyroid Nodule Diagnosis
- Avoiding Unnecessary Surgery for Thyroid Cancer
- AETNA Inc. Issues Positive Coverage Decision for ThyroSeq® Thyroid Genomic Classifier
2017
- UPMC-Developed Genetic Test Successfully Detects Some Asymptomatic Pancreatic Cancers
- UPMC test detects dangerous pancreatic cysts without surgery
- Genetic test could spare cancer patients from thyroid removal
- UPMC, Pitt partnering for thyroid cancer research
A game changer - UPMC first to explore if #cancer genetic test could be used to offer thyroid-preserving surgery: https://t.co/5AmKzACNcy pic.twitter.com/mDVxtkZnXh
— UPMC (@UPMCnews) February 9, 2017
2016
- It's Not Cancer: Doctors Reclassify a Thyroid Tumor
- A subtype of thyroid tumor isn't cancer, Pitt experts find
- With thyroid 'cancer' reclassified, patients can receive more appropriate treatment
- New UPMC test promises lower cost, more effective treatment for brain cancer
- Genetic testing at UPMC pinpoints mutations to match patients, therapies
2015
- Press Release: Pitt/UPCI Next-Gen Sequencing Test Identifies Cancerous Thyroid Nodules with High Degree of Accuracy
- Molecular characterization of sporadic pediatric thyroid carcinoma with the DNA/RNA ThyroSeq® v2 next-generation sequencing assay
- Multiple Mutations Detected Preoperatively May Predict Aggressive Behavior of Papillary Thyroid Cancer and Guide Management - A Case Report
- Impact of the Multi-Gene ThyroSeq® Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology
2014
Christine Sypien, founder of Butterfly Bandits, presents Dr. Yuri Nikiforov with a generous donation for thyroid cancer research on December 5, 2014. Butterfly Bandits' mission is to raise awareness of thyroid cancer and thyroid disease.
2013
- Gene Technology a "revolution" in cancer fight: UPMC among 7 facilities in nation using advanced gene technology in cancer fight
- UPMC Expands the Use of Next-Generation Sequencing for Cancer Patients to Guide New Therapies
- “New Diagnostic Tool Ready for Prime Time in Thyroid Cancer”
- “New Cancer Test Could Save Patients From Diagnostic Surgeries”
- “Next-generation sequencing tool shows 96% specificity in thyroid cancer detection”
- “Next Generation Sequencing Test Developed at UPMC Improves Detection of Thyroid Cancer, Reduces Unnecessary Surgeries”